Table of Contents
Breast implant lymphoma lawsuit eligibility criteria have become a critical concern for thousands of women across the United States. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare cancer of the immune system. It is not breast cancer. It develops in the scar tissue surrounding breast implants. The What Is BIA-ALCL and Why Are Women Filing Lawsuits?
BIA-ALCL stands for breast implant-associated anaplastic large cell lymphoma. It is a T-cell lymphoma that grows in the capsule of tissue around an implant. Symptoms typically include persistent fluid buildup around the implant, swelling, pain, or lumps near the breast. However, symptoms may not appear for years after implant surgery. The average time to diagnosis is 8 to 10 years after implantation. Textured breast implants carry the highest risk. According to FDA data, 481 of 573 confirmed cases involved Allergan implants. That is roughly 84 percent. Allergan BIOCELL textured implants carry approximately six times the BIA-ALCL risk compared to other textured implants. As a result, Allergan is the primary defendant in most lawsuits. Women allege the company knew about the risks but failed to warn patients and doctors. The breast implant lymphoma lawsuit eligibility criteria generally require three key elements. First, you must have received textured breast implants. Allergan BIOCELL implants are the most commonly named devices. However, other textured implant brands have also been linked to BIA-ALCL at lower rates. Smooth implants carry negligible risk. Second, you typically need a confirmed diagnosis of BIA-ALCL or BIA-SCC (squamous cell carcinoma). Diagnosis is confirmed through biopsy of fluid or capsule tissue around the implant. In most cases, your medical records must document this diagnosis. Without a confirmed diagnosis, meeting the breast implant lymphoma lawsuit eligibility criteria becomes more difficult. Third, you must demonstrate damages. For example, these can include medical bills from diagnosis and treatment, surgical costs for explant procedures, lost wages, and pain and suffering. The table below outlines common breast implant lymphoma lawsuit eligibility criteria at a glance.Breast Implant Lymphoma Lawsuit Eligibility Criteria Explained
| Requirement | Details |
|---|---|
| Implant type | Textured surface, primarily Allergan BIOCELL |
| Diagnosis | Confirmed BIA-ALCL or BIA-SCC via biopsy |
| Damages | Medical costs, explant surgery, lost income, pain and suffering |
| Statute of limitations | Typically 2–4 years from diagnosis or discovery |
| Filing location | MDL No. 2921, District of New Jersey, or state court |
Current Litigation Status and What to Expect
Most breast implant lymphoma cases are consolidated in MDL No. 2921 in the U.S. District Court for the District of New Jersey. Judge Brian R. Martinotti oversees the litigation. As of late 2025, approximately 1,261 cases were pending in the MDL. Mediation sessions were held in October 2025. However, no settlement has been announced.
The first bellwether trial is scheduled for October 19, 2026. Bellwether trials test key legal arguments before a jury. The outcome typically drives future settlement negotiations. Breast implant lymphoma lawsuit eligibility criteria may evolve as these trials proceed. For example, courts have already dismissed some claims on federal preemption grounds. Expert discovery is set to close by May 2026.
The statute of limitations varies by state. Typically, the clock starts when you receive a BIA-ALCL diagnosis. In most states, you have two to four years from that date. However, some states apply a “discovery rule.” This means the deadline starts when you learned or should have learned that your implant caused the lymphoma. Because breast implant lymphoma lawsuit eligibility criteria include time limits, acting quickly is important. Consulting an attorney as soon as possible helps protect your rights.
Steps to Take If You Think You Qualify
If you believe you meet the breast implant lymphoma lawsuit eligibility criteria, take these steps. First, gather your medical records. You need documentation of your implant type, surgery dates, and any BIA-ALCL diagnosis or symptoms. Contact your surgeon’s office or the facility where your implants were placed.
Second, identify your implant manufacturer and model. Allergan BIOCELL textured implants are linked to the majority of cases. Your surgical records or implant registration card should have this information. The FDA’s BIA-ALCL reporting page can help you understand your risk level.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Third, consult a mass tort attorney experienced in breast implant litigation. Most offer free case evaluations. They can review your breast implant lymphoma lawsuit eligibility criteria and advise whether you have a viable claim. In most cases, these attorneys work on a contingency basis. You pay nothing unless you receive compensation. Do not wait — statute of limitations deadlines can bar your claim permanently.
Frequently Asked Questions
Do I need a cancer diagnosis to file a breast implant lymphoma lawsuit?
In most cases, yes. The breast implant lymphoma lawsuit eligibility criteria typically require a confirmed BIA-ALCL diagnosis. However, some attorneys may evaluate cases involving suspicious symptoms or prophylactic explant surgery. Consult a lawyer to discuss your specific situation.
What if my implants were placed many years ago?
The age of your implants does not automatically disqualify you. BIA-ALCL can develop years or even decades after surgery. However, the statute of limitations generally runs from the date of diagnosis, not the date of implantation. As a result, the timing of your diagnosis matters most for breast implant lymphoma lawsuit eligibility criteria.
Are smooth breast implants linked to BIA-ALCL lawsuits?
Smooth-surface implants carry significantly lower risk. The vast majority of confirmed cases involve textured implants. Typically, breast implant lymphoma lawsuit eligibility criteria focus on textured devices, especially Allergan BIOCELL models. If you have smooth implants and concerns, speak with your doctor about your individual risk.
Check If You Qualify
You may be eligible for compensation from an active lawsuit and not even know it. Use our free tools to find out.
Official Sources & Resources
For verified mass tort and legal information:
- JPML (Case Data): jpml.uscourts.gov
- U.S. Department of Justice: justice.gov
- Cornell Law Institute: law.cornell.edu
- NCSL (State Laws): ncsl.org
- FDA Recalls & Safety: fda.gov
Content last reviewed June 2026. If you notice any outdated information, please contact us.
Related Guides
- Complete Mass Tort Guide
- All Active MDL Cases
- State Tort Reform Laws
- Eligibility Quiz Tool
- Damage Cap Lookup Tool
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.